These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 2686430

  • 21. Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigations.
    Harder S, Fuhr U, Staib AH, Wolff T.
    Am J Med; 1989 Nov 30; 87(5A):89S-91S. PubMed ID: 2589393
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pharmacokinetic interactions between theophylline and other medication (Part I).
    Upton RA.
    Clin Pharmacokinet; 1991 Jan 30; 20(1):66-80. PubMed ID: 1674242
    [Abstract] [Full Text] [Related]

  • 25. Effects of antacids on the clinical pharmacokinetics of drugs. An update.
    Gugler R, Allgayer H.
    Clin Pharmacokinet; 1990 Mar 30; 18(3):210-9. PubMed ID: 1969784
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Quinolone-cation interactions: a review.
    Lomaestro BM, Bailie GR.
    DICP; 1991 Nov 30; 25(11):1249-58. PubMed ID: 1763542
    [Abstract] [Full Text] [Related]

  • 34. Pharmacokinetics of fluorinated 4-quinolones in the aged.
    Norrby SR, Ljungberg B.
    Rev Infect Dis; 1989 Nov 30; 11 Suppl 5():S1102-6. PubMed ID: 2672244
    [Abstract] [Full Text] [Related]

  • 35. Adverse reactions and interactions of fluoroquinolones.
    Ball P.
    Clin Invest Med; 1989 Feb 30; 12(1):28-34. PubMed ID: 2646053
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R, Griggs D, Andrews JM.
    Rev Infect Dis; 1988 Feb 30; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [Abstract] [Full Text] [Related]

  • 37. Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database.
    Clark DW, Layton D, Wilton LV, Pearce GL, Shakir SA.
    Drug Saf; 2001 Feb 30; 24(15):1143-54. PubMed ID: 11772147
    [Abstract] [Full Text] [Related]

  • 38. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H, Quentin C, de Barbeyrac B, Bebear C.
    Pathol Biol (Paris); 1988 May 30; 36(5):496-9. PubMed ID: 3136430
    [Abstract] [Full Text] [Related]

  • 39. Complexes of ciprofloxacin with metal ions contained in antacid drugs.
    Teixeira MH, Vilas-Boas LF, Gil VM, Teixeira F.
    J Chemother; 1995 Apr 30; 7(2):126-32. PubMed ID: 7666118
    [Abstract] [Full Text] [Related]

  • 40. Drug interactions with quinolones.
    Lode H.
    Rev Infect Dis; 1988 Apr 30; 10 Suppl 1():S132-6. PubMed ID: 3279488
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.